Detailled Information

Name of the Instrument/Tool Self-Efficacy for Managing Chronic Disease (SEMCD)
First Description

Lorig, K.R., Sobel, D.S., Ritter, P.L., Laurent, D., Hobbs, M. (2001). Effect of a selfmanagement program for patients with chronic disease. Effective Clinical Practice, 4, 256-262.

Year 2014
Domains
Concept of constructs Self efficacy
Population/Disease Generic
Originally developed for Any RMD
Other rheumatic diseases
where can be applied (only if validated)
Rheumatoid Arthritis (RA), Chronic musculoskeletal pain, Systemic sclerosis
Additional population with no rheumatic diseases Yes
Chronic diseases
Language: Originally published in English
Available in Language English, German, Swedish, Arabic, Spanish
REFERENCE IDENTIFICATION
Author/s Ritter PL, Lorig K.
Title The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies.
Journal J Clin Epidemiol.
Year 2014
Vol 67
Num 11
Pages 1265-73
Country USA
Language English
Other references of interest
Link https://pubmed.ncbi.nlm.nih.gov/25091546/
Brief Description

Ritter PL, Lorig K. The English and Spanish Self-Efficacy to Manage Chronic Disease Scale measures were validated using multiple studies. J Clin Epidemiol. 2014 Nov;67(11):1265-73. doi: 10.1016/j.jclinepi.2014.06.009. Epub 2014 Aug 3. PMID: 25091546.

Link https://pubmed.ncbi.nlm.nih.gov/19781095/
Brief Description

Frei A, Svarin A, Steurer-Stey C, Puhan MA. Self-efficacy instruments for patients with chronic diseases suffer from methodological limitationsda systematic review. Health Qual Life Outcomes 2009; 7:86. http://dx.doi.org/10.1186/1477-7525-7-86

Instrument/Tool Translations References
Link https://pubmed.ncbi.nlm.nih.gov/35701627/
Brief Description

Sarhan SA, Kamal DE, Hamed MS, Mostafa DI. Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients. Clin Rheumatol. 2022 Oct;41(10):2967-2975. doi: 10.1007/s10067-022-06183-2. Epub 2022 Jun 15. PMID: 35701627; PMCID: PMC9485096.

Link https://pubmed.ncbi.nlm.nih.gov/34251963/
Brief Description

Mattsson M, Sandqvist G, Hesselstrand R, Olsson D, Kwakkenbos L, Nordin A, Boström C. Validity and reliability of the Swedish version of the Self-Efficacy for Managing Chronic Disease scale for individuals with systemic sclerosis. Scand J Rheumatol. 2022 Mar;51(2):110-119. doi: 10.1080/03009742.2021.1917142. Epub 2021 Jul 12. PMID: 34251963.

DEVELOPER CONTACT INFORMATION
Correspondence to P.L. Ritter
E-Mail philr@stanford.edu
Address Stanford Patient Education Research Center, School of Medicine, Stanford University, 1000 Welch Road, Suite 204, Palo Alto, CA 94306, USA
Website ---
Available ---
Links ---
DESCRIPTION OF THE INSTRUMENT
Type Of Measure Scale
Brief Description

Self-Efficacy for Managing Chronic Disease (SEMCD) scale has been widely used to evaluate self-efficacy of many chronic diseases as systemic sclerosis, arthritis, diabetes, heart and lung diseases, and their self-management programs. 

The SEMCD consists of six items on a 1 to 10 scale, with 1 anchored by ‘‘not at all confident’’ and 10 ‘‘totally confident.’’

Number of Items 6
Range 1-10
Responses options/scale Yes
1-10
Developed for Research, Clinical practice
PRACTICAL APPLICATION
Method of administration Self-administered
Recommendations to score

The scale is computed as the mean of the six items. If more than two of the six items are missing, the scale is set to missing.

Score Interpretation Higher scores indicate higher self-efficacy
Cut-off points ---
Cut-off points applied to ---
Smallest detectable change if described ---
Smallest detectable change applied to ---
Completion time by the patient - minutes
Scoring time by the assessor - minutes
Training to score Not necessary
Strengths Useful in clinical practice & research, Easy to use
Limitations ---
OTHER COMMENTS
Other Comments

This scale is free to use. For further information, please contact the developers.